Refractory status epilepticus with no EEG available overnight
A 59-year-old man with no prior epilepsy is brought in after 25 minutes of generalized convulsive activity witnessed by his wife. He received 10 mg of intramuscular midazolam in the field, then lorazepam 4 mg twice in the emergency department, levetiracetam 60 mg/kg, and fosphenytoin 20 mg of phenytoin equivalents/kg. He remains unresponsive with intermittent subtle right thumb twitching. He is intubated and on propofol at 30 mcg/kg/min. BP is 96/54 mmHg, HR 118, temperature 38.4 C. CT head, lumbar puncture (normal opening pressure, protein 48 mg/dL, glucose 78 mg/dL, 2 white cells), and toxicology are unrevealing. Glucose is 148 and sodium 141. Continuous EEG is requested but is not available until morning.
1. How do you classify this and what do you do in the next hour, given that no EEG is available?
Read the worked answer
This is refractory status epilepticus - persistent seizures after an adequate benzodiazepine plus a second-line agent - and the subtle thumb twitching in a comatose patient should be treated as ongoing electrographic seizure until proven otherwise.
- Assume nonconvulsive seizures are continuing. Do not wait for the EEG to escalate; the thumb twitching is a clinical surrogate for ictal activity.
- Resuscitate in parallel: fluid bolus and a vasopressor for a MAP that will not tolerate an anesthetic induction; treat the fever (38.4 C raises cerebral metabolic demand) and look for the cause with repeat cultures and a search of the history for an occult trigger.
- Start a continuous anesthetic - midazolam 0.2 mg/kg bolus then 0.1-0.2 mg/kg/h titrated up, or propofol boluses with the infusion increased - with airway and pressor support and an explicit endpoint.
- Get the earliest possible EEG, and in the interim arrange spot checks with a portable device or transfer to a monitored bed; escalate to a center with continuous EEG capability if the hospital cannot provide it.
- Beware of the pathway: if seizures continue despite a benzodiazepine, second-line agent, and one anesthetic, the next options are ketamine, additional agents, or immunosuppression if an autoimmune cause emerges.
2. What EEG endpoint do you target once monitoring is available, and how long do you maintain it?
Read the worked answer
There are two accepted targets and both are defensible; the important thing is to pick one, achieve it, and set a time limit.
- Burst suppression (suppression at least 50% of the epoch, or an isoelectric pattern) or seizure suppression with cessation of ictal discharges.
- Maintain for 24-48 hours after the last electrographic seizure, then begin a staged taper of the anesthetic by roughly 25% every 4-6 hours with EEG running continuously; a taper without monitoring is a blind trial.
- Signs of breakthrough: recurrence of discharges, repetitive twitching, pupillary or heart-rate changes, ICP rises.
Where judgment matters: treating the EEG is not the same as treating the patient. Deep suppression carries a real cost in hypotension, ileus, infection, and prolonged ventilation, and observational data in established status suggest that deeper and longer anesthetic escalation does not reliably improve functional outcome. In a patient whose cause remains unknown and whose exam is worsening, escalate, but with a defined trial period and a scheduled reassessment point with the family rather than an open-ended deepening.
3. What are the specific hazards of the anesthetic infusion, and how do you monitor for them?
Read the worked answer
Propofol infusion syndrome is the feared complication: metabolic acidosis, rising lactate, rhabdomyolysis with elevated creatine kinase, hyperkalemia, lipemia, renal failure, and refractory bradyarrhythmia progressing to cardiac arrest.
Risk rises with dose and duration - the conventional threshold is >5 mg/kg/h for more than 48 hours, but cases occur at lower doses, particularly in acute neurologic injury, children, and with catecholamines or corticosteroids.
Monitoring plan:
- Daily (or twice-daily) CK, lactate, blood gas, potassium, creatinine, triglycerides, and inspection of the serum for lipemia.
- Cap the dose at ~4-5 mg/kg/h and have a low threshold to switch to midazolam if the propofol requirement is climbing.
Midazolam brings its own problems: rapid tachyphylaxis requiring escalating doses, hypotension, and accumulation with prolonged infusion (especially with renal failure), which can leave the patient sedated for days and confound outcome assessment. Whichever agent is used, expect and prepare for hypotension with vasopressors, and pair the infusion with a scheduled maintenance antiepileptic so the taper has something underneath it.